1 / 5

Updates New Drugs Working Group & MDR Working Group

Updates New Drugs Working Group & MDR Working Group. Elizabeth Gardiner, TB Alliance Introducing New Tools & Approaches (INAT) - Berlin November 12, 2010. New Drug Working Group. Co-Chairs: Mel Spigelman & Bill Bishai

sue
Download Presentation

Updates New Drugs Working Group & MDR Working Group

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UpdatesNew Drugs Working Group & MDR Working Group Elizabeth Gardiner, TB Alliance Introducing New Tools & Approaches (INAT) - Berlin November 12, 2010

  2. New Drug Working Group • Co-Chairs: Mel Spigelman & Bill Bishai • Members: 140+ including pharmaceutical companies, TB Alliance, TAG, Community Representative (Zimbabwe), BMGF • Subgroups on Clinical Trial Capacity, Biology Targets, New Candidates, Knowledge & Tools • Focus: R&D information sharing • Website with pipeline, blog, videos • Future: introduction of new drugs

  3. Linkage with INAT • For WGND • Information about INAT • Link to INAT website, slides about what INAT is • Guidance • Who/where is the TB drug market • What patients/countries want • How can products be used • What dose works for uptake • Help Community Representative deliver the right message to the audience • For INAT • Useful pipeline for INAT • Go-to for scientific information on new drugs • Other?

  4. MDR Working Group • Chair: Ahmer Khan, Indus Hospital • Members: PIH, WHO/SEARO, WHO/GVA, Community Representatives (Nigeria & India), Union, BMGF, Resist-TB, USAID, Eli Lily, PATH • Subgroups on Research, Infection Control & Prevention, Drug Management, Diagnostics • Overseeing & providing guidance on MDR issues including subgroup topics, GLI, compassionate use, etc.

  5. Role for INAT • Should be grounded in framework of RTF • Need for coordination more than encouragement • Wants INAT to • track/disseminate info on all related new tools activities across Partnership, Department, & TDR, donor-funded activities (e.g. STREAM study, LPA studies, GenExpert availability) • identify sources of information on X, Y & Z (e.g. diagnostics, Resist-TB, TMC 207) • Advocate for new tools but through existing structures

More Related